HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.

AbstractBACKGROUND:
Moniliformediquinone (MFD), a phenanthradiquinone in Dendrobium moniliforme, was synthesized in our laboratory. Beyond its in vitro inhibitory effects on cancer cells, other biological activity of MFD is unknown. The purpose of the present study was to investigate the effects of MFD on hepatic fibrogenesis in vitro and in vivo.
METHODS:
Hepatic stellate HSC-T6 was cultured. Cell viability assay and western blot analyses were performed. Male ICR mice were evaluated on CCl4-induced hepatotoxicity using both histological examination and immunohistochemical staining.
RESULTS:
First, in vitro study showed that the synthesized MFD effectively attenuated the expression of transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF), α-smooth muscle actin (α-SMA), and type I collagen (COL-1), which modulated the hepatic fibrogenesis. Furthermore, MFD reduced the phosphorylation of p65 NFκB in HSC-T6 cells. In vivo, liver fibrosis was induced by CCl4 twice a week for 10 weeks in mice. The administration of the MFD was started after 1 week of CCl4 thrice-weekly; the MFD significantly reduced plasma aspartate transaminase (AST) and lactose dehydrogenase (LDH) as well as hepatic hydroxy-proline, α-SMA, and COL-1 expression in CCl4-treated mice. Pathological analysis showed that the MFD alleviated CCl4-induced hepatic inflammation, necrosis and fibrosis. These results suggest that MFD possesses therapeutic potential for liver fibrosis.
CONCLUSIONS:
The synthesized MFD exhibits anti-fibrotic potential by inactivation of HSCs in vitro and decreases mouse hepatic fibrosis in vivo. Further investigation into their clinical therapeutic potential is required.
AuthorsTsui-Hwa Tseng, Wea-Lung Lin, Zi-Hui Chen, Yean-Jang Lee, Ming-Shiun Shie, Kam-Fai Lee, Chien-Heng Shen, Hsing-Chun Kuo
JournalJournal of translational medicine (J Transl Med) Vol. 14 Pg. 263 (09 09 2016) ISSN: 1479-5876 [Electronic] England
PMID27612633 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2,6-dimethoxy-1,4,5,8-phenanthrenetetrone
  • Biomarkers
  • Cytokines
  • Phenanthrenes
  • Quinones
  • Carbon Tetrachloride
Topics
  • Animals
  • Biomarkers (metabolism)
  • Carbon Tetrachloride
  • Cell Line
  • Cytokines (metabolism)
  • Hepatic Stellate Cells (drug effects, metabolism, pathology)
  • Liver (drug effects, metabolism, pathology)
  • Liver Cirrhosis (drug therapy, metabolism, pathology)
  • Mice
  • Mice, Inbred ICR
  • Phenanthrenes (chemistry, pharmacology, therapeutic use)
  • Quinones (chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: